Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$20,142,212
-$657,256 QoQ
Shares Held
32,303
+20.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#213
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DDD Partners, LLC holds $20,351,126 across 2 Biotechnology names. REGN ranks #1 (99.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
32,303 | $20,142,212 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
694 | $208,914 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,142,212 | 32,303 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $20,799,468 | 26,920 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $18,581,998 | 24,074 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $12,010,649 | 21,361 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $10,760,400 | 20,496 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||